Citadel Advisors’s Checkpoint Therapeutics CKPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 5953 |
|
|
2025
Q1 | – | Sell |
-263
| Closed | -$842 | – | 6052 |
|
|
2024
Q4 | $842 | Sell |
263
-12,853
| -98% | -$41.1K | ﹤0.01% | 5848 |
|
|
2024
Q3 | $29.4K | Buy |
+13,116
| New | +$29.4K | ﹤0.01% | 5252 |
|
|
2024
Q2 | – | Sell |
-6,692
| Closed | -$13.7K | – | 6007 |
|
|
2024
Q1 | $13.7K | Buy |
+6,692
| New | +$13.7K | ﹤0.01% | 5630 |
|
|
2023
Q4 | – | Sell |
-1,898
| Closed | -$3.23K | – | 5966 |
|
|
2023
Q3 | $3.23K | Buy |
1,898
+1,138
| +150% | +$1.94K | ﹤0.01% | 5571 |
|
|
2023
Q2 | $1.88K | Buy |
+760
| New | +$1.88K | ﹤0.01% | 5563 |
|
|
2023
Q1 | – | Sell |
-64
| Closed | -$327 | – | 5985 |
|
|
2022
Q4 | $327 | Sell |
64
-1,598
| -96% | -$8.17K | ﹤0.01% | 5970 |
|
|
2022
Q3 | $17K | Sell |
1,662
-4,267
| -72% | -$43.6K | ﹤0.01% | 5564 |
|
|
2022
Q2 | $61K | Sell |
5,929
-12,053
| -67% | -$124K | ﹤0.01% | 5444 |
|
|
2022
Q1 | $318K | Buy |
17,982
+5,710
| +47% | +$101K | ﹤0.01% | 4887 |
|
|
2021
Q4 | $381K | Sell |
12,272
-8,161
| -40% | -$253K | ﹤0.01% | 4874 |
|
|
2021
Q3 | $674K | Buy |
20,433
+7,985
| +64% | +$263K | ﹤0.01% | 4211 |
|
|
2021
Q2 | $367K | Buy |
12,448
+6,154
| +98% | +$181K | ﹤0.01% | 5012 |
|
|
2021
Q1 | $198K | Buy |
+6,294
| New | +$198K | ﹤0.01% | 5422 |
|
|
2020
Q3 | – | Sell |
-2,221
| Closed | -$44K | – | 4725 |
|
|
2020
Q2 | $44K | Buy |
+2,221
| New | +$44K | ﹤0.01% | 4400 |
|